I'm not sure I want WHO to establish benchmarks. Wasn't it WHO that only wants alcohol based HS to be approved as COVID-19 killers, which effectively means ZNO can't get TGA approval? That is ironic given that alcohol based HS are amongst the least effective in terms of longetivity. I do hope that ZNO can overcome this dilemma in a timely fashion, but that will depend on the regulator not making it impossible for PH to make his case.
ZNO Price at posting:
$2.32 Sentiment: None Disclosure: Held
